HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akiyoshi Shimaya Selected Research

Insulin (Novolin)

3/2011Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist.
8/2006The novel hypoglycemic agent YM440 improves hepatic insulin resistance in obese Zucker fatty rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akiyoshi Shimaya Research Topics

Disease

5Type 2 Diabetes Mellitus (MODY)
01/2014 - 11/2006
4Insulin Resistance
03/2011 - 06/2006
2Obesity
08/2006 - 06/2006
2Glucose Intolerance
06/2006 - 07/2002
1Hypertriglyceridemia
10/2010
1Albuminuria
11/2006
1Proteinuria
11/2006
1Hyperlipidemias (Hyperlipidemia)
11/2006
1Diabetic Nephropathies (Diabetic Nephropathy)
11/2006
1Hyperglycemia
03/2003

Drug/Important Bio-Agent (IBA)

4Glucose (Dextrose)FDA LinkGeneric
03/2011 - 07/2002
4YM 440IBA
11/2006 - 07/2002
2Insulin (Novolin)FDA Link
03/2011 - 08/2006
2PPAR gammaIBA
06/2006 - 03/2003
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2014
1SecretagoguesIBA
03/2011
1Triglycerides (Triacylglycerol)IBA
10/2010
1Blood Glucose (Blood Sugar)IBA
10/2010
12- cyclopentyl- N- (2,4- dichloro- 3- ((isoquinolin- 5- yloxy)methyl)phenyl)- N- methylacetamideIBA
10/2010
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2006
12-chloro-5-nitrobenzanilideIBA
06/2006
1LigandsIBA
06/2006
1Anti-Obesity Agents (Antiobesity Drugs)IBA
06/2006
1GlycogenIBA
07/2002